# A Study to Evaluate Ethanol-induced Symptoms and Safety in Breast Cancer Patients

> **NCT06537752** · — · RECRUITING · sponsor: **Boryung Pharmaceutical Co., Ltd** · enrollment: 1052 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06537752
- **Lead sponsor:** Boryung Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-15
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 1052 (ESTIMATED)
- **Last updated:** 2025-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06537752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06537752, "A Study to Evaluate Ethanol-induced Symptoms and Safety in Breast Cancer Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06537752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*